With increasing numbers of patients needing intensive care or who are immunosuppressed,
infections caused by moulds other than Aspergillus spp or Mucorales are increasing …

The high clinical mortality and economic burden posed by invasive fungal infections (IFIs),
along with significant agricultural crop loss caused by various fungal species, has resulted in …

The epidemiology of invasive fungal infections is changing, with new populations at risk and
the emergence of resistance caused by the selective pressure from increased usage of …

The epidemiology of invasive fungal infections (IFIs) in immunocompromised individuals has
changed over the last few decades, partially due to the increased use of antifungal agents to …

Fungal infections are on the rise, driven by a growing population at risk and climate change.
Currently available antifungals include only five classes, and their utility and efficacy in …

Racial and ethnic identities, largely understood as social rather than biologic constructs,
may impact risk for acquiring infectious diseases, including fungal infections. Risk factors …

Invasive fungal disease (IFD) due to moulds other than Aspergillus is a significant cause of
mortality in patients with malignancies or post haemopoietic stem cell transplantation. The …

Scedosporium/Lomentospora fungi are increasingly recognized pathogens. As these fungi
are resistant to many antifungal agents, early diagnosis is essential for initiating targeted …

Invasive mold diseases are devastating systemic infections which demand meticulous care
in selection, dosing, and therapy monitoring of antifungal drugs. Various circumstances …

Objectives Invasive fungal infections caused by Lomentospora prolificans are associated
with very high mortality rates and can be challenging to treat given pan‐drug resistance to …